ImmuVen's Acquisition

ImmuVen was acquired by AbbVie on January 01, 2014.

ImmuVen develops drugs that can be used to treat infectious diseases and cancer. The company features life science technology, T cell receptors, a unique class of immune-targeting therapeutic and diag…

Articles about ImmuVen's Acquisition: